BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10546949)

  • 21. Management and monitoring of cancer-associated retinopathy.
    Keltner JL; Thirkill CE; Tyler NK; Roth AM
    Arch Ophthalmol; 1992 Jan; 110(1):48-53. PubMed ID: 1310001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-associated retinopathy vs recoverin-associated retinopathy.
    Keltner JL; Thirkill CE
    Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
    [No Abstract]   [Full Text] [Related]  

  • 23. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
    Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
    Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraneoplastic retinopathy syndrome.
    Thirkill CE; Roth AM; Keltner JL
    Ophthalmology; 1993 Feb; 100(2):147. PubMed ID: 8437815
    [No Abstract]   [Full Text] [Related]  

  • 25. Invasive thymoma with paraneoplastic retinopathy.
    Yamada G; Ohguro H; Aketa K; Itoh T; Shijubo N; Takahashi H; Fujiwara O; Satoh M; Ohtsuka K; Abe S
    Hum Pathol; 2003 Jul; 34(7):717-9. PubMed ID: 12874770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
    Adamus G
    Autoimmun Rev; 2003 Mar; 2(2):63-8. PubMed ID: 12848960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy.
    Adamus G; Amundson D; MacKay C; Gouras P
    Arch Ophthalmol; 1998 Feb; 116(2):251-3. PubMed ID: 9488286
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy.
    Thirkill CE; Keltner JL; Tyler NK; Roth AM
    Arch Ophthalmol; 1993 Jul; 111(7):931-7. PubMed ID: 8392327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Carcinoma-associated retinopathy: a review with clinical examples].
    Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated retinopathy.
    Thirkill CE; Roth AM; Keltner JL
    Arch Ophthalmol; 1987 Mar; 105(3):372-5. PubMed ID: 2950846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of photoreceptor cell death in cancer-associated retinopathy.
    Maeda T; Maeda A; Maruyama I; Ogawa KI; Kuroki Y; Sahara H; Sato N; Ohguro H
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):705-12. PubMed ID: 11222531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune retinopathy in the absence of cancer.
    Mizener JB; Kimura AE; Adamus G; Thirkill CE; Goeken JA; Kardon RH
    Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
    Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
    Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway.
    Shiraga S; Adamus G
    J Neuroimmunol; 2002 Nov; 132(1-2):72-82. PubMed ID: 12417436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.
    Heckenlively JR; Fawzi AA; Oversier J; Jordan BL; Aptsiauri N
    Arch Ophthalmol; 2000 Nov; 118(11):1525-33. PubMed ID: 11074809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen.
    Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
    Arch Ophthalmol; 1993 Jul; 111(7):974-8. PubMed ID: 8392328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal degeneration under the effect of antibodies to recoverin.
    Bazhin AV; Slepova OS; Tikhomirova NK
    Bull Exp Biol Med; 2001 Apr; 131(4):350-2. PubMed ID: 11550024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a photoreceptor protein, recoverin, as a cancer-associated retinopathy autoantigen in human lung cancer cell lines.
    Matsubara S; Yamaji Y; Sato M; Fujita J; Takahara J
    Br J Cancer; 1996 Nov; 74(9):1419-22. PubMed ID: 8912538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological roles of recoverin in cancer-associated retinopathy.
    Ohguro H; Nakazawa M
    Adv Exp Med Biol; 2002; 514():109-24. PubMed ID: 12596918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indocyanine green angiographic findings in nonproliferative diabetic retinopathy.
    Weinberger D; Kramer M; Priel E; Gaton DD; Axer-Siegel R; Yassur Y
    Am J Ophthalmol; 1998 Aug; 126(2):238-47. PubMed ID: 9727518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.